Viewpoints

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene panel testing can identify mutations that warrant management changes in patients who lack BRCA1 and 2.

Feature Articles

Study Suggests Caution with Information Sharing of Older Patients

Study Suggests Caution with Information Sharing of Older Patients

Sharing health information about an older patient with family may have unintended consequences.

Gynecologic Cancers Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs